ea0081p123 | Endocrine-Related Cancer | ECE2022
Silva Roman Gloria Elena
, Salazar Ma Isabel
, Taniguchi Ponciano Keiko
, Pena Martinez Juan Eduardo
, Vela Patino Sandra
, Andonegui Elguera Sergio
, Gomez Apo Erick
, Macias Laura Chavez
, Espinosa Cardenas Etual
, Ramirez Renteria Claudia
, Ferreira Hermosillo Aldo
, Sosa Ernesto
, Mercado Moises
, Marrero-Rodriguez Daniel
Pituitary adenomas (PA) are primarily benign lesions with monoclonal origins from the adenohypophyseal cells and represent 10-15% of all intracranial tumors. Tumors derived from POU1F1 cell lineage are GH-, TSH-, and PRL-secreting tumors that cause important syndromes such as acromegaly, hyperthyroidism, and sexual dysfunction, respectively. Surgical resection is the first line of treatment; the secondary treatment is pharmacological; despite having targets pharmacological in ...